These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23391651)

  • 1. [Hodgkin lymphoma and non-Hodgkin lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2013 Jan; 54(1):81-8. PubMed ID: 23391651
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
    Beck ID; Lemmel EM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.
    Glynn E; Soma L; Wu D; Wood BL; Fromm JR
    Methods Mol Biol; 2019; 1956():35-60. PubMed ID: 30779029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
    Muhonen T; Teerenhovi L; Saksela E
    Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
    Zhang QY; Foucar K
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
    Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
    Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease and non-Hodgkin lymphomas].
    Ojeda Gutiérrez E
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():44-51. PubMed ID: 10422450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant lymphoma--from the view of the clinician].
    Rák K
    Orv Hetil; 1988 Dec; 129(51):2723-7. PubMed ID: 3064022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant lymphoma].
    Stojimirović E; Jokanović R; Vuković I; Kojić V; Bubnjevacki G
    Srp Arh Celok Lek; 1973 May; 101(5):329-37. PubMed ID: 4595466
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis.
    Pellier I; Renier G; Rakotonjanahary J; Audrain M; Berardi E; Gardembas M; Clavert A; Moles MP; Proust-Houdemont S; Reguerre Y; De Carli E; Georgin-Mege M; Garo E; Blanchard S; Miot C; Picard C; Delneste Y; Fischer A; Tanguy-Schmidt A; Jeannin P
    J Allergy Clin Immunol; 2015 Mar; 135(3):818-20.e4. PubMed ID: 25420683
    [No Abstract]   [Full Text] [Related]  

  • 11. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science.
    Hochberg J; Waxman IM; Kelly KM; Morris E; Cairo MS
    Br J Haematol; 2009 Jan; 144(1):24-40. PubMed ID: 19087093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint inhibition and cellular immunotherapy in lymphoma.
    Lulla P; Heslop HE
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):390-396. PubMed ID: 27913506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biology and differentiation of lymphocytes in the classification of lymphomas].
    Mariuzzi G; Di Loreto C; Mariuzzi L
    Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

  • 15. Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma.
    Wu D; Wood BL; Fromm JR
    Methods Mol Biol; 2013; 971():27-47. PubMed ID: 23296956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.
    Khristi J; Mey U; Kirfel J; Schmidt-Wolf IG; Gütgemann I
    Ann Hematol; 2013 Nov; 92(11):1565-7. PubMed ID: 23558907
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dynamics of immunoregulator T-lymphocytes and its importance in the chemo-immunotherapy of lymphoproliferative diseases in children].
    Kadagidze ZG; Makhonova LA; Tabagari DZ; Zhogoleva IB; Maiakova SA
    Vopr Onkol; 1982; 28(5):104-9. PubMed ID: 6979828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopathology in lymphatic systemic diseases].
    Huber H; Huber C; Michlmayr G
    Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
    [No Abstract]   [Full Text] [Related]  

  • 19. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary mediastinal malignant lymphoma.
    Sutcliffe SB
    Semin Thorac Cardiovasc Surg; 1992 Jan; 4(1):55-67. PubMed ID: 1550890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.